Nonetheless, in our cohort, these data on the peritoneal carcinoma index were not available to determine those patients with the BRAF V600E mutation who are most likely to benefit from resection of peritoneal carcinomatosis, as has previously been confirmed the prognostic value of OS [33]. This evidence concerns the gene BRAF and peritoneal carcinoma.